Compounds > valproic acid

valproic acid and levonorgestrel

valproic acid has been researched along with levonorgestrel in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	2 (28.57)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Back, DJ; Chadwick, D; Cleland, P; Cowie, A; Crawford, P; Orme, ML; Tjia, J	1
Guo, SW	1
Abdulkareem, TO; Adegoke, TE; Adeyanju, OA; Dibia, C; Michael, OS; Olatunji, LA; Omotoye, OO; Oyabambi, AO; Sabinari, IW; Usman, TO	1

Reviews

1 review(s) available for valproic acid and levonorgestrel

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

6 other study(ies) available for valproic acid and levonorgestrel

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids. Contraception, 1986, Volume: 33, Issue:1 Topics: Adolescent; Adult; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Valproic Acid	1986
Valproic acid as a therapy for adenomyosis: a comparative case series. Reproductive sciences (Thousand Oaks, Calif.), 2010, Volume: 17, Issue:10 Topics: Adult; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Organ Size; Pain Measurement; Random Allocation; Uterus; Valproic Acid	2010
Allopurinol and valproic acid improve cardiac triglyceride and Na Archives of physiology and biochemistry, 2022, Volume: 128, Issue:5 Topics: Adenosine Triphosphatases; Aldosterone; Allopurinol; Animals; Contraceptives, Oral, Combined; Female; Glucose Intolerance; Humans; Insulin Resistance; Levonorgestrel; Nitric Oxide; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Triglycerides; Valproic Acid	2022